Skip to main content
CDC Website

Search Results

Results 3271 - 3280 of 17928

Worrying About Disease Progression

Worrying About Disease Progression Hep B (Web)

This infographic demonstrates how survey respondents explained how much they worry about the impact of their chronic hepatitis B on their health in the future, and how this impacts their peace of mind and anxiety levels.

Hepatitis A

Hep A (Web)

This webpage discusses hepatitis A and how it is an inflammation of the liver caused by the hepatitis A virus (HAV). The virus is primarily spread when an uninfected (and unvaccinated) person ingests food or water that is contaminated with the feces of an infected person. The disease is closely...

How do I bring up PrEP with my patients?

How to bring up PrEP with patients (Web)

How do I bring up PrEP with my patients? KFF PrEP, sex, drug use, open-ended questions, sex life, comfort   Dr. Demetre Daskalakis suggests ways that providers can bring up PrEP with their patients. One suggestion is to provide them with open-ended questions, so they are able to speak about their...

Does PrEP encourage risky behavior?

Does PrEP encourage risky behavior (Web)

Dr. Demetre Daskalakis emphasizes that prescribing PrEP does not encourage risky behavior. It is best to have open and honest conversations with patients so that they see you are giving care to the whole person as opposed to only part of them. This video is a joint production of KFF's Greater Than...

Engaging Healthcare Organizations for HIV Prevention and Care

Priorities in HIV Testing (Web)

This webinar was the final event of a three-part webinar series on Addressing Priorities in HIV Testing.  “Engaging Health Care Organizations for HIV Prevention and Care” took place on Tuesday April 23, 2024. The webinar focused on Public Health Seattle King County's EHE Healthcare Collaborative. Dr...

PrEP Landscape Updates – PS19-1906 Encore Webinar Series

PrEP Landscape Updates (Web)

The webinar focused on updates on the current PrEP landscape in the United States as it pertains to access mechanisms, telePrEP, medication and 340B pricing, and policy updates. We also discussed NASTAD’s PrEP Navigator Peer-to-Peer Group. 

Was this page helpful? Give Feedback